HOOKIPA Pharma Inc. (HOOK)
OTCMKTS · Delayed Price · Currency is USD
0.8520
+0.0314 (3.83%)
Aug 12, 2025, 9:38 AM EDT
Paramount Global Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2018 - 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2018 - 2020 |
| 9.35 | 43.95 | 20.13 | 14.25 | 18.45 | 19.58 | Upgrade | |
Revenue Growth (YoY) | -82.54% | 118.32% | 41.27% | -22.76% | -5.80% | 63.99% | Upgrade |
Cost of Revenue | 59.82 | 67.13 | 85.08 | 67.22 | 80.94 | 53.13 | Upgrade |
Gross Profit | -50.47 | -23.19 | -64.95 | -52.97 | -62.5 | -33.55 | Upgrade |
Selling, General & Admin | 24.43 | 21.6 | 19.98 | 20.19 | 19.18 | 19.74 | Upgrade |
Operating Expenses | 24.43 | 21.6 | 19.98 | 20.19 | 19.18 | 19.74 | Upgrade |
Operating Income | -74.9 | -44.79 | -84.93 | -73.16 | -81.67 | -53.29 | Upgrade |
Interest Expense | - | -0 | -0.32 | -0.69 | -0.9 | -0.79 | Upgrade |
Interest & Investment Income | 2.61 | 3.7 | 5.29 | 1.63 | 0.03 | 0.4 | Upgrade |
Other Non Operating Income (Expenses) | 4.41 | 4.15 | 11.51 | 7.52 | 6.88 | 9.59 | Upgrade |
EBT Excluding Unusual Items | -67.89 | -36.94 | -68.45 | -64.69 | -75.66 | -44.08 | Upgrade |
Merger & Restructuring Charges | -1.53 | -2.66 | - | - | - | - | Upgrade |
Asset Writedown | -4 | -4 | -12.77 | - | - | - | Upgrade |
Pretax Income | -73.42 | -43.61 | -81.21 | -64.69 | -75.66 | -44.08 | Upgrade |
Income Tax Expense | -0.11 | -0.11 | 0.37 | 0.23 | 0 | - | Upgrade |
Net Income | -73.31 | -43.5 | -81.58 | -64.92 | -75.67 | -44.08 | Upgrade |
Net Income to Common | -73.31 | -43.5 | -81.58 | -64.92 | -75.67 | -44.08 | Upgrade |
Shares Outstanding (Basic) | 13 | 13 | 9 | 7 | 3 | 3 | Upgrade |
Shares Outstanding (Diluted) | 13 | 13 | 9 | 7 | 3 | 3 | Upgrade |
Shares Change (YoY) | 16.01% | 32.65% | 44.29% | 99.53% | 26.09% | 45.80% | Upgrade |
EPS (Basic) | -5.85 | -3.47 | -8.63 | -9.91 | -23.04 | -16.93 | Upgrade |
EPS (Diluted) | -5.85 | -3.47 | -8.63 | -9.91 | -23.04 | -16.93 | Upgrade |
Free Cash Flow | -52.87 | -77.17 | -61.68 | -25.01 | -78.6 | -41.71 | Upgrade |
Free Cash Flow Per Share | -4.22 | -6.16 | -6.53 | -3.82 | -23.94 | -16.02 | Upgrade |
Gross Margin | - | -52.76% | - | - | - | -171.31% | Upgrade |
Operating Margin | -801.02% | -101.91% | -421.92% | -513.40% | -442.72% | -272.08% | Upgrade |
Profit Margin | -784.01% | -98.99% | -405.29% | -455.58% | -410.15% | -225.09% | Upgrade |
Free Cash Flow Margin | -565.37% | -175.61% | -306.44% | -175.55% | -426.05% | -212.98% | Upgrade |
EBITDA | -72.4 | -42.03 | -81.38 | -69.55 | -77.03 | -49.14 | Upgrade |
EBITDA Margin | - | -95.65% | - | - | - | -250.89% | Upgrade |
D&A For EBITDA | 2.5 | 2.75 | 3.55 | 3.6 | 4.64 | 4.15 | Upgrade |
EBIT | -74.9 | -44.79 | -84.93 | -73.16 | -81.67 | -53.29 | Upgrade |
EBIT Margin | - | -101.91% | - | - | - | -272.08% | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.